Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.

about

Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.

Item

http://www.wikidata.org/entity/Q47369973

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.

@en

Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.

@nl

type

Item

label

Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.

@en

Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.

@nl

prefLabel

Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.

@en

Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.

@nl

P1476

Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.

@en

P2093

Barry A Borlaug

http://www.w3.org/2001/XMLSchema#string

P2860

Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.

Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction

Sildenafil citrate therapy for pulmonary arterial hypertension.

Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.

Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.

Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.

Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Dias

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.

Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.

P304

126-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1002/EJHF.690

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yogesh Reddy

Barry A Borlaug

P577

2016-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27873389

http://www.w3.org/2001/XMLSchema#string